土三七致肝小静脉闭塞病13例报道及文献复习

doi:10.3969/j.issn.1672-5069.2015.02.025

Abstract

Zhou Honghua, Xu Xiaoling, Guan Xin, et al.. Hepatic veno-occlusive disease induced by senecio chrysanthemoides:An analysis of 13 cases and literature review[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 304-305.

References

[1] 彭俏,贺德志,李建生. 肝小静脉闭塞病的临床现状及研究进展.世界华人消化杂志,2012,20（12）:1030-1035.
[2] Wilmot FC,Robertson GW. Senecio disease or cirrhosis of the liver due to Senecio poisoning. Lancet,1920,2:848.
[3] Richardson PG,Guinan EC. The pathology,diagnosis,and treatment of hepatic veno-occlusive disease:current status and novel approaches. Br J Haematol,1999,107（3）:485-493.
[4] 徐静,汪茂荣.土三七导致肝小静脉闭塞综合征研究进展.实用肝脏病杂志,2013,1:94-96.
[5] 陈卫星,杨铭,虞朝辉,等. 土三七致肝小静脉闭塞病2例.中华肝脏病杂志,2005,13:394-395.
[6] 徐肇敏,诸葛宇征,徐天舒. 提高对“土三七”致肝小静脉闭塞病的认识. 胃肠病学,2009,14（10）:577-579.
[7] Chen Z,Huo JR. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med,2010,68（6）:252-260.
[8] 凌美, 武谦虎. 土三七致肝小静脉闭塞症81例文献分析.药物不良反应杂志,2013,5:254-257.
[9] 吴晓尉,朱人敏,张晓华,等. 土三七致肝小静脉闭塞病1例.实用肝脏病杂志,2010,13（2）:139-140.
[10] 陈毅鹏,李君,柴菊爱,等. 肝静脉闭塞病的临床和病理研究. 中华消化杂志,2006,26（4）:224-226.
[11] 黄焕军,刘瑶,林菊生,等.土三七致肝小静脉闭塞病诊断及治疗体会. 临床消化病杂志,2008,20（1）:26-28.
[12] Carreras E. Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur Haematol,2000,64（5）:281-291.
[13] Sayer HG,Will U,Schilling K,et al. Hepatic veno-occlusive disease（VOD） with complete occlusion of liver venules after tandem autologous stem cell transplantation-successful treatment with high-dose methylprednisolone and defibrotide. J Cancer Res Clin Oncol,2002,128（3）:148-152.
[14] Ho VT,Revta C,Richardson PG,et al. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation:update on defibrotide and other current investigational therapies. Bone Marrow Transplant,2008,41（3）:229-237.
[15] Chalandon Y,Roosnek E,Mermillod B,et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.Biol Blood Marrow Transplant,2004,10（5）:347-354. [16] Richardson PG,Murakmi C,Jin ZZ,et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure:response without significant toxicity in a high-risk population and factors predictive of outcome. Blood,2002,100（13）:4337-4343.

Hepatic veno-occlusive disease induced by senecio chrysanthemoides:An analysis of 13 cases and literature review

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.